1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2022 - Europe

Pathology Analysis & Statistics 2022 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight
1-19 of 19 reports

Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 172 pages

" Developmental and Epileptic Encephalopathy - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well as the DEE market trends ...

  • Germany
  • Spain
  • Neurological Disorder
  • Industry analysis

Anorexia - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 53 pages

‘Anorexia Nervosa (AN)- Epidemiology Forecast–2032’ report delivers an in-depth understanding of AN, historical and forecasted epidemiology as well as AN trends in the United States, EU5 (Germany, ...

  • Spain
  • Japan
  • Eating Disorder
  • Industry analysis

Post-Traumatic Stress Disorder (PTSD) - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 67 pages

" Post-traumatic stress disorder (PTSD) - Epidemiology Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and forecasted epidemiology as well ...

  • Spain
  • France
  • Anxiety Disorder
  • Industry analysis

Glaucoma - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 139 pages

‘Glaucoma—Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • United States
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Fabry Disease - Epidemiology Forecast - 2032

  • $ 3950
  • May 2022
  • 90 pages

‘Fabry Disease—Epidemiology Forecast—2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Fabry Disease in the United States, EU5 (Germany, Spain, Italy, ...

  • Spain
  • Germany
  • Neurological Disorder
  • Industry analysis

Dyslipidemia - Epidemiology Forecast to 2032

  • $ 6250
  • May 2022
  • 101 pages

‘Dyslipidemia – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Dyslipidemia in Portugal, Switzerland, Greece, Turkey, Poland, ...

  • Portugal
  • Netherlands
  • Cholesterol
  • Industry analysis
  • Smoking Prevalence

Myasthenia Gravis - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Myasthenia Gravis – Pipeline Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the pipeline drug ...

  • World
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis

Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022

  • $ 2000
  • March 2022
  • 60 pages

“Cutaneous T-Cell Lymphoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the ...

  • Poland
  • World
  • Lymphoma
  • Industry analysis

Asthma - Pipeline Insight, 2022

  • $ 3000
  • March 2022
  • 100 pages

“Asthma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Asthma pipeline landscape. It covers the pipeline drug profiles, including ...

  • World
  • China
  • Asthma
  • Industry analysis

Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 345 pages

" Developmental and Epileptic Encephalopathy - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DEE, historical and forecasted epidemiology as well ...

  • United States
  • Japan
  • Therapy
  • Neurological Disorder
  • Industry analysis
  • Drug Approval
  • Inflation Rate

Anorexia - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 107 pages

‘Anorexia nervosa-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the anorexia nervosa, historical and forecasted epidemiology as well as the ...

  • United States
  • Spain
  • Eating Disorder
  • Industry analysis
  • Depression Prevalence

Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 135 pages

"Post-traumatic stress disorder (PTSD) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Post-traumatic stress disorder (PTSD), historical and ...

  • Japan
  • United States
  • Anxiety Disorder
  • Industry analysis
  • Health Expenditure

Glaucoma - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 279 pages

‘Glaucoma—Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market ...

  • United States
  • Japan
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Fabry Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • $ 7500
  • May 2022
  • 181 pages

‘Fabry Disease—Market Insights, Epidemiology, and Market Forecast—2032’ report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Fabry ...

  • Japan
  • United States
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Nosocomial pneumonia - Pipeline Insight, 2022

  • $ 1500
  • March 2022
  • 50 pages

“Nosocomial pneumonia- Pipeline Insight, 2022” report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Nosocomial pneumonia pipeline landscape. It covers the pipeline drug ...

  • World
  • Europe
  • Infectious Disease
  • Industry analysis
  • Hospital Admission

NF-kappa B Inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 90 pages

“NF-kappa B Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in NF-kappa B Inhibitors pipeline landscape. It covers the pipeline ...

  • World
  • Europe
  • Therapy
  • Cancer
  • Industry analysis

Capsid protein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Capsid protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 9+ companies and 9+ pipeline drugs in Capsid protein inhibitors pipeline landscape. It covers the pipeline ...

  • Ireland
  • World
  • Therapy
  • Hepatitis
  • Industry analysis

Viral core protein inhibitors - Pipeline Insight, 2022

  • $ 1500
  • January 2022
  • 60 pages

“Viral core protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Viral core protein inhibitors pipeline landscape. It covers ...

  • Ireland
  • World
  • Therapy
  • Hepatitis
  • Industry analysis

Chemotherapy Induced Anemia - Pipeline Insight, 2022

  • $ 1250
  • March 2022
  • 40 pages

“Chemotherapy Induced Anemia- Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chemotherapy Induced Anemia pipeline landscape. It covers the ...

  • World
  • China
  • Blood Disease
  • Chemotherapy
  • Industry analysis
  • Energy Supply


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on